Introduction
Tobacco use spread around the world from its origins in the Americas (Box 1). Early anecdotal accounts of tobacco's captivating influence and of associated health consequences inspired research into its addictive properties. However, our present molecular and cellular concepts of nicotine addiction (see Glossary) arising from tobacco use are relatively recent. The specific investigation of nicotine addiction arose from a long history of basic cholinergic research. It is valuable, captivating and, for some of us, even romantic to look back at the early work that laid the foundation for our present understanding of nicotine addiction. The early discovery of autonomic cholinergic transmission and nicotinic acetylcholine receptors (nAChRs) spurred physiological characterization of the neuromuscular junction (NMJ). Those studies served as guideposts, or they may more appropriately be called points-of-reference, for the more recent investigations that revealed surprisingly different and diverse mechanisms of nicotinic cholinergic transmission in the brain. Most commonly, humans self-administer nicotine using an exquisite dosing device, the cigarette. Acting directly and mainly through nAChRs, nicotine impinges upon neural circuitry that shapes short-term and long-term behavior. This review provides a compact summary of tobacco use and the scientific advances that led to the modern research into nicotine addiction. We hope this brief article and the referenced review publications and books will inspire both novices and experts to explore these fascinating historical events further.
Brief history of nicotinic cholinergic signaling As tobacco use spread around the world (Box 1), interest in the active ingredients and their effects stimulated scientific investigation. Early in the 20th century, nicotine had been synthesized and the classic studies of drug action by John Newport Langley and his colleagues had begun [1] . These initial efforts with nicotine culminated in the 1905 study in which Langley refers to the 'receptive substance' that would eventually turn out to be nAChRs [2] .
As the concepts of specific receptors, drug pharmacology and synaptic transmission were being formulated and advanced (Figure 1 ), Otto Loewi published the results of his most famous experiment, indicating the importance of neurotransmitters in chemical neural communication [3] (Figure 2 ). Two frog hearts were separately bathed in saline solutions, and the vagus nerve was stimulated to slow the beat of one frog heart. When solution was taken from that bath and applied to the second bath, it slowed the beat of the second frog heart. This 'Vagusstoff', as Loewi termed it, was identified by Henry Dale and his colleagues Review Glossary Addiction: a state in which drug taking is out of control. Chronic exposure to drugs of dependence evoke changes in the central and peripheral nervous systems that cause the behavioral and somatic signs of withdrawal when drug taking is terminated abruptly. Anhedonia: a state in which the ability of the individual to experience and respond to pleasurable stimuli is blunted. Conditioned cues/stimuli: this refers to cues or stimuli that are paired repeatedly with the delivery of the addictive drug (or reward). The cues may be sensory (e.g. stimulus lights or tones) and applied within a behavioral chamber where they are tightly associated with the delivery of a drug of abuse (e.g. nicotine) or environmental contextual cues that relate to the availability of nicotine. Mesocorticolimbic dopamine system: a neural pathway in the brain that projects from the midbrain to the cortex, the limbic structures, and extending to the striatum to include the NAc of the ventral striatum. The neurons release the neurotransmitter dopamine, which has been implicated in the reinforcing properties of drugs of abuse. Nicotine withdrawal: the somatic, emotional and behavioral symptoms exhibited when nicotine is abruptly withdrawn following a period of chronic treatment or self-administration. Receptor up-regulation: an increase in the density and/or function of the receptor evoked by chronic exposure to a drug. Chronic exposure to nicotine has been shown to cause up-regulation of nicotinic receptors in brains of both experimental animals and human smokers. 
